GEMPSIIVO
REGENXBIO Inc.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 98196371 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | William R. Samuels |
| Attorney Docket Number | 1959.26 |
Timeline
| 2023-09-25 | Application Filed |
| 2023-09-28 | Location: NEW APPLICATION PROCESSING |
| 2023-09-28 | Status: Live/Pending |
| 2023-09-28 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  REGENXBIO Inc. |
| Address | 9804 Medical Center Drive Rockville MD 20850 |
| Legal Entity Type | Corporation |
| Legal Entity State | MD |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Biological preparations for medical use; pharmaceutical preparations, namely, recombinant adeno-associated viral (rAAV) vectors for use in gene therapy; Pharmaceutical preparations for the treatment of genetic diseases and disorders and central nervous system (CNS) disorders, namely neurodegenerative disorders; Pharmaceutical preparations for use in gene therapy; Clinical medical reagents for use in gene therapy; Pharmaceutical preparations for the treatment of genetic disorders and neurodegenerative disorders; Therapeutic pharmaceutical compositions that include recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy; Pharmaceutical preparations containing adeno-associated viral (AAV) vectors and nucleic acids for a system delivering genes to biological cells for use in the treatment of diseases, sicknesses, and disorders, namely, lysosomal storage disorders; gene therapy preparation containing genetic materials for sustained protein expression, namely lysosomal enzyme expression |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED | 2023-09-28 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2023-10-10 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2024-04-10 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2024-04-17 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2024-04-17 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2024-04-17 | 6 GNRN O:Outgoing Correspondence |
| APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | 2024-07-10 | 7 XELR I:Incoming Correspondence |
| APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | 2024-07-10 | 8 XELG O:Outgoing Correspondence |
| TEAS VOLUNTARY AMENDMENT RECEIVED | 2024-07-24 | 9 PARI I:Incoming Correspondence |
| PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | 2024-07-24 | 10 AMPX O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 